Overproduction of large VLDL particles is driven by increased liver fat content in man

Use and Abuse of HOMA Modeling

Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114 · see citing works

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · see citing works

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · see citing works

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176 · see citing works

Nonalcoholic Fatty Liver Disease

Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581 · see citing works

Molecular mediators of hepatic steatosis and liver injury

Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772 · see citing works

Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM

Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · see citing works

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex

Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483 · see citing works

Banting Lecture 2001

McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435 · see citing works

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,328 · see citing works

Adiponectin and Metabolic Syndrome

Matsuzawa, Y., Funahashi, T., Kihara, S., & Shimomura, I. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000099786.99623.ef · Cited by 1,203 · see citing works

Splanchnic lipolysis in human obesity

Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933 · see citing works

Diabetic dyslipidaemia: from basic research to clinical practice*

Taskinen, M.-R. (2003) · Diabetologia · doi:10.1007/s00125-003-1111-y · Cited by 888 · see citing works

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

Vozarova, B., Stefan, N., Lindsay, R. S., Saremi, A., Pratley, R. E., Bogardus, C., & Tataranni, P. A. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1889 · Cited by 717 · see citing works

Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus

Shimomura, I., Bashmakov, Y. K., & Horton, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30028 · Cited by 708 · see citing works

Plasma Adiponectin Concentrations Predict Insulin Sensitivity of Both Glucose and Lipid Metabolism

Tschritter, O., Fritsche, A., Thamer, C., Haap, M. M., Shirkavand, F., Rahe, S., Staiger, H., Maerker, E., Häring, H. U., & Stümvoll, M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.239 · Cited by 585 · see citing works

Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets

Schwarz, J.-M., Linfoot, P., Dare, D., & Aghajanian, K. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.43 · Cited by 496 · see citing works

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.

Ryysy, L., Häkkinen, A. M., Goto, T., Vehkavaara, S., Westerbacka, J., Halavaara, J., & Yki-Järvinen, H. (2000) · Diabetes · doi:10.2337/diabetes.49.5.749 · Cited by 431 · see citing works

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance

Kelley, D. E., McKolanis, T. M., Hegazi, R. A. F., Kuller, L. H., & Kalhan, S. C. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00117.2003 · Cited by 426 · see citing works

Elevations in Markers of Liver Injury and Risk of Type 2 Diabetes

Hanley, A. J., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., Kempf, J., Zinman, B., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2623 · Cited by 386 · see citing works

Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients

Bajaj, M. S., Suraamornkul, S., Piper, P. K., Hardies, L. J., Glass, L. C., Cersósimo, E., Pratipanawatr, T., Miyazaki, Y., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031315 · Cited by 354 · see citing works

Hypoadiponectinemia Is Closely Linked to Endothelial Dysfunction in Man

Shimabukuro, M., Higa, N., Asahi, T., Oshiro, Y., Takasu, N., Tagawa, T., Ueda, S., Shimomura, I., Funahashi, T., & Matsuzawa, Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021883 · Cited by 346 · see citing works

Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk

Westerbacka, J., Corn�r, A., Tiikkainen, M., Tamminen, M., Vehkavaara, S., H�kkinen, A.-M., Fredriksson, J., & Yki-J�rvinen, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1460-1 · Cited by 338 · see citing works

Quantification of liver fat using magnetic resonance spectroscopy

Thomsen, C., Becker, U., Winkler, K., Christoffersen, P., Jensen, M., & Henriksen, O. (1994) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(94)92543-7 · Cited by 332 · see citing works

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.

Malmström, R., Packard, C. J., Caslake, M., Bedford, D., Stewart, P., Yki-Järvinen, H., Shepherd, J., & Taskinen, M.-R. (1997) · Diabetologia · doi:10.1007/s001250050700 · Cited by 319 · see citing works

Correlation Between Adiponectin, Tumor Necrosis Factor-alpha, Insulin Resistance and Atherogenic Dyslipidemia in Non Diabetic Central Obese Males

Ninghayu, C., Wijaya, A., & As’ád, S. (2010) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v2i1.113 · Cited by 305 · see citing works

Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease

Tamura, S., & Shimomura, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24930 · Cited by 288 · see citing works

The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat.

Nieves, D. J., Cnop, M., Retzlaff, B., Walden, C. E., Brunzell, J. D., Knopp, R. H., & Kahn, S. E. (2003) · Diabetes · doi:10.2337/diabetes.52.1.172 · Cited by 281 · see citing works

Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity

Rashid, S., Watanabe, T., Sakaue, T., & Lewis, G. F. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00078-x · Cited by 277 · see citing works

Overproduction of VLDL 1 Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia

Adiels, M., Borén, J., CASLAKE, M. J., Stewart, P., Soro, A., Westerbacka, J., Wennberg, B., Olofsson, S., Packard, C. J., & Taskinen, M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000172689.53992.25 · Cited by 270 · see citing works

Synthesis and function of hepatic very-low-density lipoprotein

Gibbons, G. F., Wiggins, D. K., Brown, A.-M., & Hebbachi, A.-M. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320059 · Cited by 254 · see citing works

Adiponectinemia in Visceral Obesity: Impact on Glucose Tolerance and Plasma Lipoprotein and Lipid Levels in Men

Côté, M., Mauriège, P., Bergeron, J., Alméras, N., Tremblay, A., Lemieux, I., & Després, J.-P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1711 · Cited by 230 · see citing works

Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men

Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168 · see citing works

Glucose and Insulin Function through Two Distinct Transcription Factors to Stimulate Expression of Lipogenic Enzyme Genes in Liver

Koo, S., Stoeckman, A. K., & Towle, H. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010029200 · Cited by 160 · see citing works

Decreased Plasma Lipoprotein Lipase in Hypoadiponectinemia

von Eynatten, M., Schneider, J. G., Humpert, P. M., Rudofsky, G., Schmidt, N., Barosch, P., Hamann, A., Morcos, M., Kreuzer, J., Bierhaus, A., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2925 · Cited by 138 · see citing works

Circulating Adiponectin Levels Are Reduced in Nonobese but Insulin-Resistant First-Degree Relatives of Type 2 Diabetic Patients

Pellmé, F., Smith, U., Funahashi, T., Matsuzawa, Y., Brekke, H. K., Wiklund, O., Taskinen, M., & Jansson, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1182 · Cited by 134 · see citing works

Phosphoinositide 3-Kinase Activity Is Necessary for Insulin-dependent Inhibition of Apolipoprotein B Secretion by Rat Hepatocytes and Localizes to the Endoplasmic Reticulum

Phung, T. L., Roncone, A. M., Jensen, K. L. D. M., Sparks, C. E., & Sparks, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30693 · Cited by 121 · see citing works

The Fatty Liver and Insulin Resistance

Yki-Järvinen, H., & Westerbacka, J. (2005) · Current Molecular Medicine · doi:10.2174/1566524053766031 · Cited by 120 · see citing works

A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions

Adiels, M., Packard, C. J., CASLAKE, M. J., Stewart, P., Soro, A., Westerbacka, J., Wennberg, B., Olofsson, S., Taskinen, M., & Borén, J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400108-jlr200 · Cited by 117 · see citing works

Separate Contribution of Diabetes, Total Fat Mass, and Fat Topography to Glucose Production, Gluconeogenesis, and Glycogenolysis

Gastaldelli, A., Miyazaki, Y., Pettiti, M., Buzzigoli, E., Mahankali, S., Ferrannini, E., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031941 · Cited by 117 · see citing works

Adipocytokines and VLDL Metabolism

Ng, T. W., Watts, G. F., Farvid, M. S., Chan, D. C., & Barrett, P. H. R. (2005) · Diabetes · doi:10.2337/diabetes.54.3.795 · Cited by 108 · see citing works

Regulation of Microsomal Triglyceride Transfer Protein Gene by Insulin in HepG2 Cells

Au, W.-S., Kung, H.-F., & Lin, M. C.-M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1073 · Cited by 108 · see citing works

Ameliorated Hepatic Insulin Resistance Is Associated with Normalization of Microsomal Triglyceride Transfer Protein Expression and Reduction in Very Low Density Lipoprotein Assembly and Secretion in the Fructose-fed Hamster

Carpentier, A. C., Taghibiglou, C., Leung, N. M., Szeto, L., Iderstine, S. C. V., Uffelman, K. D., Buckingham, R. E., Adeli, K., & Lewis, G. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204568200 · Cited by 97 · see citing works

Adiponectin and other Adipocytokines as Predictors of Markers of Triglyceride-Rich Lipoprotein Metabolism

Chan, D. C., Watts, G. F., Ng, T. W., Uchida, Y., Sakai, N., Yamashita, S., & Barrett, P. H. R. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.045120 · Cited by 97 · see citing works

Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes

Hiukka, A., Fruchart‐Najib, J., Leinonen, E. S., Hilden, H., Fruchart, J., & Taskinen, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1753-z · Cited by 96 · see citing works

Regulation of Hepatic Apolipoprotein B-lipoprotein Assembly and Secretion by the Availability of Fatty Acids

Zhang, Y., Hernández‐Ono, A., Ko, C., Yasunaga, K., Huang, L., & Ginsberg, H. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400220200 · Cited by 94 · see citing works

Insulin Inhibits the Maturation Phase of VLDL Assembly via a Phosphoinositide 3-Kinase—Mediated Event

Brown, A.-M., & Gibbons, G. F. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.096640 · Cited by 89 · see citing works

Insulin Sensitivity of Suppression of Endogenous Glucose Production Is the Single Most Important Determinant of Glucose Tolerance

Båvenholm, P., Pigon, J., Östenson, C., & Efendić, S. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1449 · Cited by 81 · see citing works

Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects

Gill, J. M. R., Brown, J. C., Bedford, D. K., Wright, D. M., Cooney, J., Hughes, D. A., Packard, C. J., & CASLAKE, M. J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.022 · Cited by 79 · see citing works

LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins

Vakkilainen, J., Jauhiainen, M., Ylitalo, K., Nuotio, I. O., Viikari, J. S. A., Ehnholm, C., & Taskinen, M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31489-9 · Cited by 63 · see citing works

Both Insulin Resistance and Diabetes inPsammomys obesusUpregulate the Hepatic Machinery Involved in Intracellular VLDL Assembly

Zoltowska, M., Ziv, E., DELVIN, E. E., Lambert, M. A., Seidman, E. G., & Levy, E. H. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000105901.18785.99 · Cited by 26 · see citing works

Glucose Phosphorylation Is Essential for the Turnover of Neutral Lipid and the Second Stage Assembly of Triacylglycerol-Rich ApoB-Containing Lipoproteins in Primary Hepatocyte Cultures

Brown, A.-M., Wiggins, D. K., & Gibbons, G. F. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.321 · Cited by 26 · see citing works

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100 · see citing works

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765 · see citing works

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601 · see citing works

Body Fat Distribution and Risk of Cardiovascular Disease: An Update

Després, J.-P. (2012) · Circulation · doi:10.1161/circulationaha.111.067264 · Cited by 1,481 · see citing works

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

Ipsen, D. H., Lykkesfeldt, J., & Tveden-Nyborg, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2860-6 · Cited by 1,471 · see citing works

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972 · see citing works

Gender differences in insulin resistance, body composition, and energy balance

Geer, E. B., & Shen, W. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.02.002 · Cited by 913 · see citing works

Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications

Cusi, K. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 912 · see citing works

Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease

Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R. A., Bugianesi, E., & Gastaldelli, A. (2013) · Nutrients · doi:10.3390/nu5051544 · Cited by 824 · see citing works

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome

Adiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820 · see citing works

Fatty Liver

Kotronen, A., & Yki‐Järvinen, H. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 793 · see citing works

Age-related changes in total and regional fat distribution

Kuk, J. L., Saunders, T. J., Davidson, L. E., & Ross, R. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.06.001 · Cited by 778 · see citing works

Sugar consumption, metabolic disease and obesity: The state of the controversy

Stanhope, K. L. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1084990 · Cited by 739 · see citing works

Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis

Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R. W., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001680 · Cited by 727 · see citing works

Pathophysiology of diabetic dyslipidaemia: where are we?

Vergès, B. (2015) · Diabetologia · doi:10.1007/s00125-015-3525-8 · Cited by 708 · see citing works

Metabolic-associated fatty liver disease and lipoprotein metabolism

Heeren, J., & Scheja, L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101238 · Cited by 666 · see citing works

Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease

Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.038 · Cited by 631 · see citing works

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.

Korenblat, K. M., Fabbrini, E., Mohammed, B. S., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.075 · Cited by 592 · see citing works

Complications, morbidity and mortality of nonalcoholic fatty liver disease

Mantovani, A., Scorletti, E., Mosca, A., Alisi, A., Byrne, C. D., & Targher, G. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154170 · Cited by 558 · see citing works

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

Targher, G., & Arcaro, G. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.021 · Cited by 551 · see citing works

Causes and Metabolic Consequences of Fatty Liver

Stefan, N., Kantartzis, K., & Häring, H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 527 · see citing works

The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis

Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 531 · see citing works

Type 2 Diabetes

Taylor, R. (2013) · Diabetes Care · doi:10.2337/dc12-1805 · Cited by 485 · see citing works

From the metabolic syndrome to NAFLD or vice versa?

Vanni, E., Bugianesi, E., Kotronen, A., Minicis, S. D., Yki‐Järvinen, H., & Svegliati‐Baroni, G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.016 · Cited by 494 · see citing works

Metabolic syndrome

Neeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463 · see citing works

Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for β cell recovery

Taylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., Hollingsworth, K. G., Mathers, J. C., Sattar, N., & Lean, M. E. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.003 · Cited by 450 · see citing works

Liver Fat in the Metabolic Syndrome

Kotronen, A., Westerbacka, J., Bergholm, R., Pietiläinen, K. H., & Yki‐Järvinen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0482 · Cited by 452 · see citing works

New insights into the pathophysiology of dyslipidemia in type 2 diabetes

Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440 · see citing works

Gene expression in human NAFLD

Greco, D., Kotronen, A., Westerbacka, J., Puig, O., Arkkila, P., Kiviluoto, T., Laitinen, S., Kolak, M., Fisher, R. M., Hamsten, A., et al. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00074.2008 · Cited by 427 · see citing works

Sex Differences in Lipid and Lipoprotein Metabolism: It's Not Just about Sex Hormones

Wang, X., Magkos, F., & Mittendorfer, B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2061 · Cited by 423 · see citing works

Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome

Dekker, M. J., Su, Q., Baker, C., Rutledge, A. C., & Adeli, K. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00283.2010 · Cited by 419 · see citing works

Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance

Choi, S. H., & Ginsberg, H. N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.007 · Cited by 418 · see citing works

NAFLD: Mechanisms, Treatments, and Biomarkers

Nassir, F. (2022) · Biomolecules · doi:10.3390/biom12060824 · Cited by 422 · see citing works

Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis

Anderson, N., & Borlak, J. T. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 384 · see citing works

Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents

Ota, T., Gayet, C., & Ginsberg, H. N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32752 · Cited by 376 · see citing works

Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease

Azzu, V., Vacca, M., Virtue, S., Allison, M., & Vidal-Puig, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.054 · Cited by 369 · see citing works

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease

ter Horst, K. W., & Serlie, M. J. M. (2017) · Nutrients · doi:10.3390/nu9090981 · Cited by 365 · see citing works

Arsenic and Cardiovascular Disease

States, J. C., Srivastava, S., Chen, Y., & Barchowsky, A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn236 · Cited by 351 · see citing works

Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis

Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L. J. C., Jackson, S. J., Vottero, A., Kanabar, D. J., Charlton-Menys, V., Durrington, P. N., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37432 · Cited by 347 · see citing works

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

Matikainen, N., Mänttäri, S., Schweizer, A., Ulvestad, A., Mills, D., Dunning, B. E., Foley, J. E., & Taskinen, M.-R. (2006) · Diabetologia · doi:10.1007/s00125-006-0340-2 · Cited by 336 · see citing works

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

Duran, E. K., Aday, A. W., Cook, N. R., Buring, J. E., Ridker, P. M., & Pradhan, A. D. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.059 · Cited by 336 · see citing works

Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia

Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00676-y · Cited by 315 · see citing works

Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans

Pafili, K., & Roden, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101122 · Cited by 330 · see citing works

Activation of Peroxisome Proliferator–Activated Receptor (PPAR)δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men

Risérus, U., Sprecher, D. L., Johnson, T., Olson, E., Hirschberg, S., Liu, A., Fang, Z., Hegde, P. S., Richards, D. B., Sarov-Blat, L., et al. (2007) · Diabetes · doi:10.2337/db07-1318 · Cited by 326 · see citing works

Hepatic lipid metabolism and non-alcoholic fatty liver disease

Tessari, P., Coracina, A., Cosma, A., & Tiengo, A. (2009) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.12.015 · Cited by 314 · see citing works

Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity

Kolak, M., Westerbacka, J., Velagapudi, V., Wågsäter, D., Yetukuri, L., Makkonen, J., Rissanen, A., Häkkinen, A., Lindell, M., Bergholm, R., et al. (2007) · Diabetes · doi:10.2337/db07-0111 · Cited by 318 · see citing works

Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease

Lara‐Castro, C., Fu, Y., Chung, B. H., & Garvey, W. T. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32814a645f · Cited by 315 · see citing works

The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state

Hodson, L., & Gunn, P. J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0256-9 · Cited by 311 · see citing works

Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease

Sullivan, S. A., Kirk, E. P., Mittendorfer, B., Patterson, B. W., & Klein, S. (2011) · Hepatology · doi:10.1002/hep.25548 · Cited by 303 · see citing works

Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro

Pirazzi, C., Adiels, M., Burza, M. A., Mancina, R. M., Levin, M. C., Ståhlman, M., Taskinen, M., Orho‐Melander, M., Perman, J., Pujia, A., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.030 · Cited by 300 · see citing works

New insulin delivery recommendations

Frid, A. H., Kreugel, G., Grassi, G., Halimi, S., Hicks, D., Hirsch, L. J., Smith, M. J., Wellhoener, R., Bode, B. W., Hirsch, I. B., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.06.010 · Cited by 286 · see citing works

Understanding the mechanisms of reversal of type 2 diabetes

Taylor, R., Al-Mrabeh, A., & Sattar, N. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30076-2 · Cited by 299 · see citing works

Hepatic Selective Insulin Resistance at the Intersection of Insulin Signaling and Metabolic Dysfunction-Associated Steatotic Liver Disease

Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293 · see citing works

Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots.

Hocking, S. L., Samocha-Bonet, D., Milner, K.-L., Greenfield, J., & Chisholm, D. (2013) · Endocrine reviews · doi:10.1210/er.2012-1041 · Cited by 261 · see citing works

A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults

Stanhope, K. L., Medici, V., Bremer, A. A., Lee, V., Lam, H. D., Nunez, M. V., Chen, G. X., Keim, N. L., & Havel, P. J. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.100461 · Cited by 270 · see citing works

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease

Luukkonen, P. K., Dufour, S., Lyu, K., Zhang, X., Hakkarainen, A., Lehtimäki, T. E., Cline, G. W., Petersen, K. F., Shulman, G. I., & Yki‐Järvinen, H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922344117 · Cited by 253 · see citing works

Body Fat Distribution and Inflammation Among Obese Older Adults With and Without Metabolic Syndrome

Koster, A., Stenholm, S., Alley, D. E., Kim, L. J., Simonsick, E. M., Kanaya, A. M., Visser, M., Houston, D. K., Nicklas, B. J., Tylavsky, F. A., et al. (2010) · Obesity · doi:10.1038/oby.2010.86 · Cited by 249 · see citing works

Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver

Kotronen, A., Seppänen‐Laakso, T., Westerbacka, J., Kiviluoto, T. A., Arola, J. T., Ruskeepää, A., Orešič, M., & Yki‐Järvinen, H. (2008) · Diabetes · doi:10.2337/db08-1074 · Cited by 247 · see citing works

Causes and consequences of hypertriglyceridemia

Packard, C. J., Boren, J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00252 · Cited by 239 · see citing works

Ectopic lipid storage and insulin resistance: a harmful relationship

Borén, J., Taskinen, M., Olofsson, S. ‐., & Levin, M. C. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12071 · Cited by 234 · see citing works

Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia

Sparks, J. D., Sparks, C. E., & Adeli, K. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241463 · Cited by 237 · see citing works

Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile

Siddiqui, M. S., Fuchs, M. A., Idowu, M. O., Luketic, V. A., Boyett, S. L., Sargeant, C., Stravitz, R. T., Puri, P., Matherly, S. C., Sterling, R. K., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.008 · Cited by 231 · see citing works

Dietary Lipid Levels Influence Lipid Deposition in the Liver of Large Yellow Croaker (Larimichthys crocea) by Regulating Lipoprotein Receptors, Fatty Acid Uptake and Triacylglycerol Synthesis and Catabolism at the Transcriptional Level

Yan, J., Liao, K., Wang, T., Mai, K., Xu, W., & Ai, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129937 · Cited by 224 · see citing works

Pathogenesis of nonalcoholic steatohepatitis

Liu, W., Baker, R. D., Bhatia, T., Zhu, L., & Baker, S. S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2161-x · Cited by 225 · see citing works

Role of Fructose-Containing Sugars in the Epidemics of Obesity and Metabolic Syndrome

Stanhope, K. L. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042010-113026 · Cited by 222 · see citing works

Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans

Sevastianova, K., Santos, A., Kotronen, A., Hakkarainen, A., Makkonen, J., Silander, K., Peltonen, M., Romeo, S., Lundbom, J., Lundbom, N., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.038695 · Cited by 211 · see citing works

NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men

Targher, G., Bertolini, L., Rodella, S., Lippi, G., Franchini, M., Zoppini, G., Muggeo, M., & Day, C. P. (2008) · Obesity · doi:10.1038/oby.2008.64 · Cited by 214 · see citing works

Hypertriglyceridemia secondary to obesity and diabetes

Subramanian, S., & Chait, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.003 · Cited by 200 · see citing works

Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance

Adiels, M., Westerbacka, J., Soro‐Paavonen, A., Häkkinen, A. ‐., Vehkavaara, S., CASLAKE, M. J., Packard, C. J., Olofsson, S.-O., Yki‐Järvinen, H., Taskinen, M., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0790-1 · Cited by 197 · see citing works

Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations

Kotronen, A., Velagapudi, V. R., Yetukuri, L., Westerbacka, J., Bergholm, R., Ekroos, K., Makkonen, J., Taskinen, M.-R., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetologia · doi:10.1007/s00125-009-1282-2 · Cited by 198 · see citing works

Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects

Kotronen, A., Juurinen, L., Hakkarainen, A., Westerbacka, J., Cornér, A., Bergholm, R., & Yki-Järvinen, H. (2008) · Diabetes Care · doi:10.2337/dc07-1463 · Cited by 196 · see citing works

Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease

Park, H., Shima, T., Yamaguchi, K., Mitsuyoshi, H., Minami, M., Yasui, K., Itoh, Y., Yoshikawa, T., Fukui, M., Hasegawa, G., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0291-8 · Cited by 194 · see citing works

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

Borén, J., Packard, C. J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00474 · Cited by 196 · see citing works

Metabolically healthy obesity across the life course: epidemiology, determinants, and implications

Phillips, C. M. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13230 · Cited by 189 · see citing works

Hepatic Steatosis as a Marker of Metabolic Dysfunction

Fabbrini, E., & Magkos, F. (2015) · Nutrients · doi:10.3390/nu7064995 · Cited by 191 · see citing works

The regulation of ApoB metabolism by insulin

Haas, M. E., Attie, A., & Biddinger, S. B. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.04.001 · Cited by 189 · see citing works

Postprandial hypertriglyceridemia as a coronary risk factor

Borén, J., Matikainen, N., Adiels, M., & Taskinen, M.-R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.015 · Cited by 182 · see citing works

New injection recommendations for patients with diabetes

Frid, A. H., Hirsch, L. J., Gaspar, R., Hicks, D., Kreugel, G., Liersch, J., Letondeur, C., Sauvanet, J.-P., Tubiana‐Rufi, N., & Strauss, K. W. (2010) · Diabetes & Metabolism · doi:10.1016/s1262-3636(10)70002-1 · Cited by 177 · see citing works

Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD

Mardinoğlu, A., Björnson, E., Zhang, C., Klevstig, M., Söderlund, S., Ståhlman, M., Adiels, M., Hakkarainen, A., Lundbom, N. M. I., Kiliçarslan, M., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167422 · Cited by 177 · see citing works

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids

Orešič, M., Hyötyläinen, T., Kotronen, A., Gopalacharyulu, P. V., Nygrén, H., Arola, J. T., Castillo, S., Mattila, I. M., Hakkarainen, A., Borra, R., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2981-2 · Cited by 168 · see citing works

Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD

Bril, F., Sninsky, J. J., Baca, A. M., Superko, H. R., Portillo-Sánchez, P., Biernacki, D., Maximos, M., Lomonaco, R., Orsak, B., Suman, A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3111 · Cited by 168 · see citing works

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk

Glavinovic, T., Thanassoulis, G., Graaf, J. D., Couture, P., Hegele, R. A., & Sniderman, A. D. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025858 · Cited by 166 · see citing works

Thyroid hormone-related regulation of gene expression in human fatty liver.

Pihlajamäki, J., Boes, T., Kim, E.-Y., Dearie, F., Kim, B. W., Schroeder, J., Mun, E., Nasser, I., Park, P. J., Bianco, A. C., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0212 · Cited by 164 · see citing works

Recent advances in pharmacotherapy for hypertriglyceridemia

Sahebkar, A., Chew, G. T., & Watts, G. F. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.07.002 · Cited by 166 · see citing works

Naringenin Decreases Progression of Atherosclerosis by Improving Dyslipidemia in High-Fat–Fed Low-Density Lipoprotein Receptor–Null Mice

Mulvihill, E. E., Assini, J. M., Sutherland, B. G., DiMattia, A. S., Khami, M., Koppes, J. B., Sawyez, C. G., Whitman, S. C., & Huff, M. W. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.201095 · Cited by 164 · see citing works

Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome

Deushi, M., Nomura, M., Kawakami, A., Haraguchi, M., Ito, M., Okazaki, M., Ishii, H., & Yoshida, M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.023 · Cited by 163 · see citing works

Hepatic Fatty Acid Trafficking: Multiple Forks in the Road

Mashek, D. G. (2013) · Advances in Nutrition · doi:10.3945/an.113.004648 · Cited by 162 · see citing works

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches

Nikolić, D., Katsiki, N., Montalto, G., Isenović, E. R., Mikhailidis, D. P., & Rizzo, M. (2013) · Nutrients · doi:10.3390/nu5030928 · Cited by 160 · see citing works

Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review

Oscarsson, J., & Hurt-Camejo, E. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0541-3 · Cited by 158 · see citing works

Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects

Taskinen, M.-R., Adiels, M., Westerbacka, J., Söderlund, S., Kahri, J., Lundbom, N., Lundbom, J., Hakkarainen, A., Olofsson, S.-O., Orho-Melander, M., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.224808 · Cited by 153 · see citing works

Nutritional Systems Biology Modeling: From Molecular Mechanisms to Physiology

de Graaf, A. A., Freidig, A. P., de Roos, B., Jamshidi, N., Heinemann, M., Rullmann, J. A. C., Hall, K. D., Adiels, M., & van Ommen, B. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000554 · Cited by 155 · see citing works

Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality

Brouwers, M. C. G. J., Simons, N., Stehouwer, C. D. A., & Isaacs, A. J. (2019) · Diabetologia · doi:10.1007/s00125-019-05024-3 · Cited by 153 · see citing works

Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis

Pingitore, P., Sasidharan, K., Ekstrand, M., Prill, S., Lindén, D., & Romeo, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071629 · Cited by 152 · see citing works

Triglycerides as vascular risk factors: new epidemiologic insights.

Kannel, W. B., & Vasan, R. S. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832c1284 · Cited by 149 · see citing works

Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism

Kersten, S. (2007) · PPAR Research · doi:10.1155/2008/132960 · Cited by 147 · see citing works

Fructose consumption: recent results and their potential implications

Stanhope, K. L., & Havel, P. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05266.x · Cited by 148 · see citing works

Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease

Wang, J., He, W., Tsai, P.-J., Chen, P.-H., Ye, M., Guo, J., & Su, Z. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01210-0 · Cited by 147 · see citing works

Fatty liver, insulin resistance, and dyslipidemia

Adiels, M., Taskinen, M., & Borén, J. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0011-4 · Cited by 146 · see citing works

Activation of a Specific Gut Bacteroides-Folate-Liver Axis Benefits for the Alleviation of Nonalcoholic Hepatic Steatosis

Qiao, S., Li, B., Wang, K., Sun, S., Liao, M., Liu, C., Zhou, N., Ma, K., Zhang, Y., Chen, Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108005 · Cited by 147 · see citing works

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

Fruchart, J.-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Després, J.-P., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0864-7 · Cited by 140 · see citing works

Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance

Adiels, M., Westerbacka, J., Soro‐Paavonen, A., Häkkinen, A. ‐., Vehkavaara, S., CASLAKE, M. J., Packard, C. J., Olofsson, S.-O., Yki‐Järvinen, H., Taskinen, M., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0790-1 · Cited by 197 · see citing works

Overproduction of VLDL 1 Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia

Adiels, M., Borén, J., CASLAKE, M. J., Stewart, P., Soro, A., Westerbacka, J., Wennberg, B., Olofsson, S., Packard, C. J., & Taskinen, M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000172689.53992.25 · Cited by 270 · see citing works

Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes

Vergès, B. L. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.028 · Cited by 95 · see citing works

Type 2 Diabetes as a Lipid Disorder

Taskinen, M. (2005) · Current Molecular Medicine · doi:10.2174/1566524053766086 · Cited by 135 · see citing works

Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: Effects of obesity and non-insulin-dependent diabetes mellitus

Howard, B. V., Abbott, W. G. H., Egusa, G., & Taskinen, M. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90625-9 · Cited by 39 · see citing works